Clinical Trial Update: Study of Bevacizumab in Combination with Alternating XELIRI and XELOX in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bevacizumab in combination with alternating XELIRI and XELOX regimens for metastatic colorectal cancer; status is active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Pia Osterlund | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING